array(3) { ["company_details"]=> array(13) { ["name"]=> string(29) "Novartis Gene Therapies, Inc." ["slug"]=> string(19) "a26d9-us-avexis-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/35cea00f-69c0-468d-b166-ddd4f49dfa0c" ["description"]=> string(639) "Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. Around 108,000 people of more than 140 nationalities work at Novartis around the world. See our community guidelines: http://bit.ly/2JnT2CP" ["address_street"]=> string(24) "2275 Half Day Rd Ste 200" ["address_place"]=> string(11) "Bannockburn" ["address_region"]=> string(8) "Illinois" ["founding_date"]=> string(10) "2010-02-28" ["website_domain"]=> string(12) "novartis.com" ["website_url"]=> string(24) "https://www.novartis.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(219) ["article_count"]=> int(7829) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(65) "Novartis receives German green light for acquisition of Morphosys" ["snippet_en"]=> string(94) "The authority did not detect any threat to the research and development of new leukemia drugs." ["url"]=> string(100) "https://agefi.com/actualites/entreprises/novartis-recoit-le-feu-vert-allemand-au-rachat-de-morphosys" ["image_url"]=> string(78) "https://images.businessradar.com/articles/af094781-0f47-4e5d-aabe-639d3aec79ee" ["source"]=> string(9) "agefi.com" ["publication_date"]=> string(10) "2024-03-12" ["categories"]=> array(2) { [0]=> string(11) "Acquisition" [1]=> string(5) "R & D" } } [1]=> array(7) { ["title_en"]=> string(107) "siRNA drug that revolutionizes treatment and works for six months with a single injection (Nikkei Business)" ["snippet_en"]=> string(98) "Novartis develops and manufactures innovative drugs. Novartis develops and manufactures innovative" ["url"]=> string(35) "https://newspicks.com/news/9630082/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/62f31c96-56c8-4513-bdbb-1362a4dac43c" ["source"]=> string(13) "newspicks.com" ["publication_date"]=> string(10) "2024-02-25" ["categories"]=> array(1) { [0]=> string(5) "R & D" } } [2]=> array(7) { ["title_en"]=> string(80) "USIU Africa will host 3rd Regional AI and Machine Learning Conference in Nairobi" ["snippet_en"]=> string(155) "The event aims to empower Africa to tackle existing challenges and position itself as a forerunner in sustainable development and technological innovation." ["url"]=> string(79) "https://www.cryptopolitan.com/sv/usiu-afrika-att-vara-vard-for-en-ai-konferens/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/ce20914a-69e1-47d8-b338-d023c2fd4649" ["source"]=> string(17) "cryptopolitan.com" ["publication_date"]=> string(10) "2024-02-25" ["categories"]=> array(3) { [0]=> string(22) "Sustainable Investment" [1]=> string(5) "Event" [2]=> string(5) "R & D" } } [3]=> array(7) { ["title_en"]=> string(75) "Global Posterior Microsurgical Instruments Market Research Report 2024-2030" ["snippet_en"]=> string(75) "Global Posterior Microsurgical Instruments Market Research Report 2024-2030" ["url"]=> string(134) "https://industrytoday.co.uk/market-research-industry-today/global-posterior-microsurgical-instruments-market-research-report-2024-2030" ["image_url"]=> NULL ["source"]=> string(19) "industrytoday.co.uk" ["publication_date"]=> string(10) "2024-02-21" ["categories"]=> array(4) { [0]=> string(33) "Materials Sourcing and Efficiency" [1]=> string(5) "R & D" [2]=> string(15) "Market Movement" [3]=> string(17) "Academic Research" } } [4]=> array(7) { ["title_en"]=> string(67) "Will we have drugs developed by artificial intelligence? - The post" ["snippet_en"]=> string(145) "Some of the largest and most powerful pharmaceutical companies are evaluating the merits and defects of AI to reduce costs and failures in trials" ["url"]=> string(66) "https://www.ilpost.it/2024/02/05/farmaci-intelligenza-artificiale/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/bc875973-3fa4-424d-af56-9b25cd0c8845" ["source"]=> string(9) "ilpost.it" ["publication_date"]=> string(10) "2024-02-05" ["categories"]=> array(3) { [0]=> string(15) "Deals & Tenders" [1]=> string(20) "Business Development" [2]=> string(5) "R & D" } } [5]=> array(7) { ["title_en"]=> string(76) "Research: Fedriga, AstraZeneca agreement favors life sciences sector (VIDEO)" ["snippet_en"]=> string(234) ""This agreement is part of the path started two years ago which aims to strongly strengthen the life sciences and scientific research sector in Friuli Venezia Giulia. The interest of Novartis first and now of AstraZeneca for the [...]" ["url"]=> string(120) "https://www.triestecafe.it/it/news/cronaca/ricerca-fedriga-accordo-astrazeneca-favorisce-settore-scienze-vita-video.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/7f2c57ad-5a7f-4322-8ebc-a5c5cc966d95" ["source"]=> string(14) "triestecafe.it" ["publication_date"]=> string(10) "2024-02-02" ["categories"]=> array(5) { [0]=> string(13) "Collaboration" [1]=> string(18) "General Investment" [2]=> string(7) "Economy" [3]=> string(5) "R & D" [4]=> string(17) "Academic Research" } } [6]=> array(7) { ["title_en"]=> string(41) "Novartis: We did not withdraw from Turkey" ["snippet_en"]=> string(202) "Novartis made a statement regarding the allegations that they withdrew from Turkey: "We would like to inform the public that we will continue to contribute to the growth and development of our country."" ["url"]=> string(75) "https://www.gazeteduvar.com.tr/novartis-turkiyeden-cekilmedik-haber-1664948" ["image_url"]=> string(78) "https://images.businessradar.com/articles/05e735dd-1a4f-4709-b514-c6ed16fcf734" ["source"]=> string(18) "gazeteduvar.com.tr" ["publication_date"]=> string(10) "2024-01-26" ["categories"]=> array(2) { [0]=> string(14) "Product Recall" [1]=> string(5) "R & D" } } [7]=> array(7) { ["title_en"]=> string(51) "Life sciences location Tyrol is growing dynamically" ["snippet_en"]=> string(136) "Plant construction & process technology Plant construction & process technology Plant construction & process technology Chemistry & Life" ["url"]=> string(85) "https://www.chemanager-online.com/news/life-sciences-standort-tirol-waechst-dynamisch" ["image_url"]=> NULL ["source"]=> string(21) "chemanager-online.com" ["publication_date"]=> string(10) "2024-01-24" ["categories"]=> array(3) { [0]=> string(18) "Expansion & Growth" [1]=> string(33) "Materials Sourcing and Efficiency" [2]=> string(5) "R & D" } } [8]=> array(7) { ["title_en"]=> string(96) "Artificial intelligence drives the pharmaceutical industry to develop dramatically in the future" ["snippet_en"]=> string(96) "Artificial intelligence drives the pharmaceutical industry to develop dramatically in the future" ["url"]=> string(107) "https://vietq.vn/tri-tue-nhan-tao-thuc-day-nganh-duoc-pham-phat-trien-vuot-bac-trong-tuong-lai-d218227.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/848f351b-a0ba-45fc-a11b-aa3f4b0685c8" ["source"]=> string(8) "vietq.vn" ["publication_date"]=> string(10) "2024-01-23" ["categories"]=> array(2) { [0]=> string(13) "Collaboration" [1]=> string(5) "R & D" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(527) } [1]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(450) } [2]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(433) } [3]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(306) } [4]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(302) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(242) } [6]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(238) } [7]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(232) } [8]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(194) } [9]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(189) } [10]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(179) } [11]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(163) } [12]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(161) } [13]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(160) } [14]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(143) } [15]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(133) } [16]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(130) } [17]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(125) } [18]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(119) } [19]=> array(2) { ["name"]=> string(8) "spin-off" ["count"]=> int(114) } [20]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(112) } [21]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(108) } [22]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(98) } [23]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(98) } [24]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(85) } [25]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(85) } [26]=> array(2) { ["name"]=> string(7) "Layoffs" ["count"]=> int(81) } [27]=> array(2) { ["name"]=> string(15) "Business Ethics" ["count"]=> int(80) } [28]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(78) } [29]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(74) } } } a26d9-us-avexis-inc